This was determined using an angiotensin II (Ang II) model of hypertension, in which the blood pressure elevation induced by 14 days of subcutaneous Ang II infusion was indistinguishable between wild-type and Trpa1-KO mice. This evidence concerns the gene AGT and hypertensive disorder.